An observational study in Memory Disorders, sponsored by University Hospital, Tours. Recruiting at 1 site in France. Open to participants aged 50 Years and older. Per ClinicalTrials.gov, last updated 2026-04-30.
Sponsored by University Hospital, Tours · Observational
Episodic memory (EM) is a neuropsychological marker of Alzheimer's disease (AD) (Thomas-Anterion, 2006). Current tests for its assessment do not take into account the identity and emotional aspects of memory (Van der Linden et al., 2018). However, there are models that integrate links with identity, self-awareness and experience. Pause et al. (2013) propose criteria to create ecological tools, including consideration of the emotional valence of memories and the spatio-temporal context of acquisition. In line with these criteria, we have developed a new tool: the NEM (New evaluation of Episodic Memory). Preliminary studies show different response profiles on the NEM among patients (Launay et al., 2023). We now want to evaluate the relevance of this tool in the differential diagnosis of AD.
373 studies on the registry are indexed under Memory Disorders; 67 are open to participants now.
This study's planned enrollment of 150 is below the median of 187 across 62 observational studies indexed under Memory Disorders.
Browse Memory Disorders studies →University Hospital, Tours is the lead sponsor of 307 studies on the registry; 79 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patient attending a memory consultation for suspected Alzheimer's disease.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
patients benefiting from the new memory assessment
Other: New memory assessment
The intervention is part of the neuropsychological assessment carried out as part of routine care. It consists of carrying out the neuropsychological tests traditionally used to investigate the diagnostic hypothesis of Alzheimer's disease.
Score total NEM (new memory assessment)
Sum of the episodic elements
Time frame: baseline
NEM sub-scores
Sum of the episodic elements by category
Time frame: baseline
Total RL/RI 16 Recall
(Van der Linden et al., 2014)
Time frame: baseline
Delayed Mem Logic Recall
(MEM IV, Wechsler, 2014)
Time frame: baseline
Plan to share: Undecided
No publications or documents are linked to this record.
Started Nov 2024 (actual). Primary completion is estimated for Nov 2028, 48 months after the start.
Of 23 observational studies under Memory Disorders, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 208. This study's planned 48 months is above that.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.